Vimarsana
Biggest News Aggregation in the World

Page 27 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting - Vimarsana News

Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
SOTIO Biotech: SOTIO Announces Oral and Multiple Poster Presentations on Key Clinical Programs at the American Association of Cancer Research Annual Meeting (AACR) 2022 - Vimarsana News

SOTIO Biotech: SOTIO Announces Oral and Multiple Poster Presentations on Key Clinical Programs at the American Association of Cancer Research Annual Meeting (AACR) 2022

Oral presentation will focus on interim efficacy and safety data from the Phase 1/1b AURELIO-03 study of SOT101 in combination with pembrolizumabPoster presentations will feature preclinical data on SOTIO's

TYME Technologies, Inc. Announces SM-88 Poster at the - Vimarsana News

TYME Technologies, Inc. Announces SM-88 Poster at the

-- Preclinical results from Georgetown University support that SM-88 is potentially a novel anti-cancer agent in drug resistant estrogen receptor positive...

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference - Vimarsana News

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference - Vimarsana News

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...